Cloud-clone
SKU:LMF757Hu
Magnetic Luminex Assay Kit for Peroxiredoxin 2 (PRDX2) ,etc.
Magnetic Luminex Assay Kit for Peroxiredoxin 2 (PRDX2) ,etc.
Couldn't load pickup availability
Product No.
LMF757Hu
Organism Species
Homo sapiens (Human).
Sample Type
Serum, plasma, tissue homogenates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
1.95-2000pg/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.65 pg/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex.
Specificity
This assay has high sensitivity and excellent specificity for detection of Peroxiredoxin 2 (PRDX2) ,etc..
No significant cross-reactivity or interference between Peroxiredoxin 2 (PRDX2) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Peroxiredoxin 2 (PRDX2) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Peroxiredoxin 2 (PRDX2) ,etc. in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 93-105 | 101 |
| EDTA plasma(n=5) | 88-101 | 93 |
| heparin plasma(n=5) | 78-101 | 84 |
| sodium citrate plasma(n=5) | 89-103 | 95 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Peroxiredoxin 2 (PRDX2) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Peroxiredoxin 2 (PRDX2) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Peroxiredoxin 2 (PRDX2) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 91-103% | 96-105% | 80-90% | 99-105% |
| EDTA plasma(n=5) | 93-101% | 89-103% | 97-105% | 86-94% |
| heparin plasma(n=5) | 78-95% | 80-95% | 80-96% | 82-103% |
| sodium citrate plasma(n=5) | 86-98% | 94-103% | 83-101% | 80-88% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| 96-well plate | 1 | Plate sealer for 96 wells | 4 |
| Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
| Pre-Mixed Magnetic beads (22#:PRDX2) | 1 | Analysis buffer | 1×20mL |
| Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
| Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
| Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
| Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
| Magazine | Citations |
| Free Radical Research | Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress Pubmed:25564095 |
| PLoS One | Differences in Proinflammatory Property of Six Subtypes of Peroxiredoxins and Anti-Inflammatory Effect of Ligustilide in Macrophages pubmed:27716839 |
| Experiental And Therapeutic Medicine | Plasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription pubmed:28672924 |
| Oncotarget | Neuroprotective effect of a novel gastrodin derivative against ischemic brain injury: involvement of peroxiredoxin and TLR4 signaling inhibition pubmed:29207618 |
| European Journal of Applied Physiology | Prolonged forearm ischemia attenuates endothelium-dependent vasodilatation and plasma nitric oxide metabolites in overweight middle-aged men Pubmed:29785503 |
| Journal of Applied Physiology | Montmorency cherry supplementation attenuates vascular dysfunction induced by prolonged forearm occlusion in overweight middle-aged men Pubmed: 30496705 |
| ACS Omega | SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics 34250342 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPF757Hu02 | Recombinant Peroxiredoxin 2 (PRDX2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF757Hu03 | Recombinant Peroxiredoxin 2 (PRDX2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF757Hu01 | Recombinant Peroxiredoxin 2 (PRDX2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF757Hu01 | Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| PAF757Hu03 | Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| PAF757Hu02 | Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| MAF757Hu23 | Monoclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| MAF757Hu21 | Monoclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB |
| WEF757Hu | Wide-range ELISA Kit for Peroxiredoxin 2 (PRDX2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEF757Hu | ELISA Kit for Peroxiredoxin 2 (PRDX2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF757Hu | Magnetic Luminex Assay Kit for Peroxiredoxin 2 (PRDX2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
